Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.
Clinical trial NCT00210743 · COMPLETED
Trial details
- NCT number
- NCT00210743
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.